The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cumulative antibiotic use and efficacy of immune checkpoint inhibitors in patients with advanced cancer.
 
Nadina Tinsley
No Relationships to Disclose
 
Cong Zhou
No Relationships to Disclose
 
Shaun Villa
Honoraria - Envision Communications
 
Grace Tan
No Relationships to Disclose
 
Paul Lorigan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; NeraCare GmbH; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Fiona Helen Blackhall
Honoraria - AstraZeneca; Medivation; Pfizer
Consulting or Advisory Role - AstraZeneca; cell Medica; Medivation
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Tony Elliott
Research Funding - Astellas Medivation; AstraZeneca; Bayer; BMS Brazil; Janssen; Roche
 
Matthew Krebs
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; Octimet; Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Louise Carter
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb
Travel, Accommodations, Expenses - BerGenBio; BerGenBio
 
Fiona Thistlethwaite
Honoraria - Novartis
Consulting or Advisory Role - Achilles Therapeutics; Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Evelo Therapeutics; Octimet (Inst); Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb
Research Funding - Aveo (Inst); GenMab (Inst); MedImmune (Inst); Novartis (Inst); Pfizer (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; IPSEN
Other Relationship - Novartis; Pfizer
 
Andrew Hughes
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Carrick Therapeutics; PCI Biotech; Roche
Research Funding - AstraZeneca
 
Natalie Cook
No Relationships to Disclose